Article

Urology Times, Digital Edition, September 2011

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Subscribe Now!
Related Videos
Justin Dubin, MD, on leveraging digital tools to improve patient buy-in
Justin Dubin, MD, on leveraging digital tools to improve patient buy-in
1 expert is featured in this series.
Approaching Corticosteroid Selection With Abiraterone in Patients With High-Risk Localized or Locally Advanced Prostate Cancer
1 expert is featured in this series.
Incorporating Micronized Abiraterone and Low-Fat Meal Dosing: Monitoring Efficacy and Tolerability
DNA helix | Image Credit: © Radomir Jovanovic - stock.adobe.com
Betty Wang, MD, and Laura Bukavina, MD, MPH, MSc, discuss ctDNA's role in NMIBC treatment decisions
Andrea Pezzella, MD, URPS, FACOG, discusses Neuspera's integrated sacral neuromodulation system
Andrea Pezzella, MD, URPS, FACOG, discusses Neuspera's integrated sacral neuromodulation system
The Growing Call for Combination Therapy in NMIBC Treatment
The Growing Call for Combination Therapy in NMIBC Treatment
Optimizing NMIBC Treatment Through Sequencing and Patient Preference
Optimizing NMIBC Treatment Through Sequencing and Patient Preference
Mina Fam, MD, on managing expectations around testosterone replacement therapy
Mina Fam, MD, on managing expectations around testosterone replacement therapy
Justin Dubin, MD, on the role for AI in patient education
Justin Dubin, MD, on the role for AI in patient education
Considerations for pre-procedure urinalysis, periprocedural antibiotics for onabotA
Considerations for pre-procedure urinalysis, periprocedural antibiotics for onabotA
Related Content
Study shows favorable outcomes with guideline-based treatment for localized prostate cancer
July 14th 2025

Study shows favorable outcomes with guideline-based treatment for localized prostate cancer

Hannah Clarke
“Our data support adherence to guideline recommendations for treatment of prostate cancer,” says Pietro Scilipoti, MD.
Pearls & Perspectives: Disruptive Innovation in Urology, with Sijo J. Parekattil, MD
June 30th 2025

Pearls & Perspectives: Disruptive Innovation in Urology, with Sijo J. Parekattil, MD

Amy M. Pearlman, MD
Pearlman and Parekattil dig deep into novel surgical and non-surgical approaches to chronic orchialgia and pelvic pain.
Patient talking with a doctor | Image Credit: © Pcess609 - stock.adobe.com
July 10th 2025

FDA grants breakthrough device designation for ArteraAI Prostate tool

Benjamin P. Saylor Hannah Clarke
“This designation is a powerful validation of our software's potential to transform how we treat cancer,” said Andre Esteva, CEO of Artera.
Pearls & Perspectives: Sexual Health in MSM, with Joshua R. Gonzalez, MD
June 19th 2025

Pearls & Perspectives: Sexual Health in MSM, with Joshua R. Gonzalez, MD

Amy M. Pearlman, MD
The conversation covers practical, case-based strategies for counseling MSM patients.
Prostate cancer cells dividing | Image Credit: © PRB ARTS - stock.adobe.com
July 10th 2025

EMBARK: Significant OS gains seen with enzalutamide plus leuprolide in nmHSPC

Benjamin P. Saylor
According to the news release, detailed OS data from EMBARK are set to be presented at an upcoming medical conference.
FDA grants fast track designation to TRE-515 with 177Lu-PSMA-617 for mCRPC
July 9th 2025

FDA grants fast track designation to TRE-515 with 177Lu-PSMA-617 for mCRPC

Benjamin P. Saylor Hannah Clarke
The investigational treatment is being evaluated in phase 1 clinical trials for solid tumors.
© 2025 MJH Life Sciences

All rights reserved.